{"url_path":"/sec/slbt/10-k/2026/item-7","section_key":"item-7","section_title":"Item 7 MAJOR SHAREHOLDERS AND RELATED PARTY","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-06-18","source_url":"https://www.sec.gov/Archives/edgar/data/2070534/0001213900-26-070158-index.html","accession_number":"0001213900-26-070158","cik":"0002070534","ticker":"SLBT","issuer_name":"SL Science Holding Ltd","edgar_url":"https://www.sec.gov/Archives/edgar/data/2070534/0001213900-26-070158-index.html","primary_entity_key":"0002070534","primary_entity_name":"SL Science Holding Ltd"},"word_count":920,"has_tables":true,"body_markdown":"** **\n\n**ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY\nTRANSACTIONS**\n\n** **\n\n**A.**\n**Major Shareholders**\n\nThe following table sets forth information regarding the beneficial\nownership of Ordinary Shares as of June 18, 2026 by:\n\n●each person known by us to be the beneficial owner of more\nthan 5% of Ordinary Shares;\n\n●\neach of our directors and executive officers; and\n\n●\nall our directors and executive officers as a group.\n\nBeneficial ownership is determined\naccording to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if that person possesses\nsole or shared voting or investment power over that security. A person is also deemed to be a beneficial owner of securities that the\nperson has a right to acquire within 60 days including, without limitation, through the exercise of any option, warrant or other right\nor the conversion of any other security. Such securities, however, are deemed to be outstanding only for the purpose of computing the\npercentage beneficial ownership of that person but are not deemed to be outstanding for the purpose of computing the percentage beneficial\nownership of any other person. Under these rules, more than one person may be deemed to be a beneficial owner of the same securities.\n\nThe calculations of the percentage of beneficial ownership are based on 560,759,757 Ordinary Shares issued and outstanding, as of June\n18, 2026, which does not include 260,000 Ordinary Shares convertible on December 12, 2026 from 780,000 Preferred Shares issued and outstanding\nas of June 18, 2026.\n\nUnless otherwise indicated,\nwe believe that all persons named in the table below have sole voting and investment power with respect to all Ordinary Shares beneficially\nowned by them.\n\n27\n\n**Name of Beneficial Owner**\n\n** **\n\n** **\n\nOrdinary\n\nShares\n\n% of Total\n\nOrdinary\n\nShares /\n\nVoting Power\n\n**Principal Shareholders(1)**\n\nSL Link Holding Ltd.(2)\n333,832,129\n\n59.53%\n\nDirectors and Executive Officers\n\nWilliam Wang(2)\n333,832,129\n\n59.53%\n\nRay Leung\n—\n\nJohnson Lau\n—\n\nEthan Shen, Ph.D.\n—\n\nKwo-Liang Chen\n—\n\nMingche Liu, M.D., Ph.D.\n—\n\nJohn C. General\n—\n\nJoseph Levinson\n—\n\nQian (Hebe) Xu\n20,000\n\n*\n\nAll directors and executive officers as a group (9 individuals)\n333,852,129\n\n59.54%\n\n*\nLess than 1% of the total number of outstanding Ordinary Shares\n\n(1)\nUnless otherwise noted, the business address of each of the following entities or individuals is c/o SL Science Holding Limited, 11th Floor, No. 479 Chongyang Road, Nangang District, Taipei, Taiwan R.O.C. 115010.\n\n(2)\nRepresents 333,832,129 Ordinary Shares beneficially owned by William Wang, including (i) 329,286,823 Ordinary Shares held by SL Link Holding\nLtd., and (ii) 4,545,306 Ordinary Shares held by SL Link Co., Ltd. SL Link Holding Ltd. is a company incorporated in the Cayman Islands\nwhich is owned equally by Mr. Wang and his spouse, and Mr. Wang is the sole director of SL Link Holding Ltd. SL Link Co., Ltd. is a company\nincorporated in Taiwan. Mr. Wang owns a 50.63% equity interest of SL Link Co., Ltd., and is the Chairman of the Board and Chief Executive\nOfficer of SL Link Co., Ltd. As a result, Mr. Wang is deemed to have voting and dispositive power over the securities of the Company held\nby SL Link Holding Ltd. and SL Link Co., Ltd.\n\n**B.**\n**Related Party Transactions**\n\nAs of December 31, 2025, 2024, and 2023 SL Bio and its’\nsubsidiaries have no amount due from (to) affiliates.\n\nIn January 2023, SL Bio\nentered into an operating lease arrangement with SL Link to lease part of its office premises in Taiwan. The lease has the initial term\nof 53 months from January 1, 2023 to May 31, 2027, but the lease was cancelled in December 2024. As of December 31,\n2024 and 2023, the lease has the outstanding lease term of nil and 41 months, respectively. In January 2023, SL Bio also entered\ninto a corporate and administrative service agreement with SL Link for the general corporate and accounting services in Taiwan, and it\nwas terminated in December 2024.\n\n28\n\nDuring the year ended December 31,\n2025, the Company had the following transactions with affiliates:\n\nName\nAmount\nRelationship\nNote\n\nJY BioMed\n$455,714\nCompany owned by our Chief Technical Officer of the Company, Dr. Shen\nResearch and development costs paid for GDT Cells Licenses to the Group\n\nDuring the year ended December 31,\n2024, SL Bio had the following transactions with affiliates:\n\nName\nAmount\nRelationship\nNote\n\nSL Link\n$167,795\nCompany owned by a director and a shareholder of SL Bio, Mr. Wang\nOperating leasing income for the rental of office premise to the Group\n\nSL Link\n$80,496\nCompany owned by a director and a shareholder of SL Bio, Mr. Wang\nExpenses for general corporate and accounting services provided to the Group\n\nSL Link\n$949,771\nCompany owned by a director and a shareholder of SL Bio, Mr. Wang\nResearch and development costs paid for the transfer of the CD-19 Patent to the Group\n\nJY BioMed\n$964,823\nCompany owned by our Chief Technology Officer of the Company, Dr. Shen\nResearch and development costs paid for GDT Cells Licenses to the Group\n\nDuring the year ended December 31,\n2023, SL Bio had the following transaction with affiliates:\n\nName\nAmount\nRelationship\nNote\n\nSL Link\n$173,173\nCompany owned by a director and a shareholder of SL Bio, Mr. Wang\nOperating leasing income for the rental of office premise to the Group\n\nSL Link\n$83,076\nCompany owned by a director and a shareholder of SL Bio, Mr. Wang\nExpenses for general corporate and accounting services provided to the Group\n\n**C.**\n**Interests of Experts and Counsel**\n\nNone / Not applicable.\n\n29"}